AGL-2263 is an insulin receptor (IR) blocker.
AGL-2263 is an insulin receptor (IR) blocker[1].
[1]. Li Y, et al. GDM-associated insulin deficiency hinders the dissociation of SERT from ERp44 and down-regulates placental 5-HT uptake. Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):E5697-705.
















